Skip to main content
. 2020 May 30;21(11):3931. doi: 10.3390/ijms21113931

Figure 4.

Figure 4

CHIR99021 is a potent Wnt activator in CASCs but slightly decreased its viability. (A) Representative Western blots (left panels) and subsequent quantification (right panels) of both total and active β-catenin after CHIR99021 treatment. (B) Cell viability of CASCs, as well as 293T and SW480 cells, treated with 6 µM CHIR99021. Data are shown as medians ± IQR (n = 6 individual patient CASC cultures/condition); * p < 0.05 compared to respective control.